Although no significant differences in PUMA mRNA levels were induced by treatment (Supplementary Figures S5E), FOXO3a mRNA levels were upregulated by approximately 2-fold in BTZ mono- and BTZ + TMZ combination treated P3 GBM cells respectively (p < .05) compared to TMZ treatment alone. This evidence concerns the gene CASC3 and glioblastoma.